Affimed
AFMD
#11118
Rank
NZ$5.19 M
Marketcap
NZ$0.32
Share price
0.00%
Change (1 day)
N/A
Change (1 year)

Earnings for Affimed (AFMD)

Earnings in 2024 (TTM): -NZ$0.13 Billion

According to Affimed 's latest financial reports the company's current earnings are NZ$0.96 Million. In 2023 the company made an earning of -NZ$0.21 Billion a decrease over its 2022 earnings that were of -NZ$0.16 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Affimed from 2013 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -NZ$0.13 Billion-38.34%
2023 -NZ$0.21 Billion26.6%
2022 -NZ$0.16 Billion36.51%
2021 -NZ$0.12 Billion38.05%
2020 -NZ$84.06 Million33.51%
2019 -NZ$62.97 Million54.17%
2018 -NZ$40.84 Million-32.35%
2017 -NZ$60.37 Million-3.51%
2016 -NZ$62.57 Million60.24%
2015 -NZ$39.05 Million3296.68%
2014 -NZ$1.15 Million-98.1%
2013 -NZ$60.52 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Repligen
RGEN
NZ$0.13 B-202.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Merrimack Pharmaceuticals
MACK
-NZ$3.95 Million-97.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
NZ$0.20 B-256.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
-NZ$0.48 Billion 255.38%๐Ÿ‡บ๐Ÿ‡ธ USA